RECRUITING

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Talk to us

Conditions

Hematopoietic Stem Cell Transplantstem cell transplantpositive psychology intervention

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.

Official Title

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Quick Facts

Study Start:2024-11-20
Study Completion:2030-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06328127

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
  2. * Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
  3. * Access to a basic telephone
  1. * Patients who underwent allogeneic HSCT for benign hematologic conditions
  2. * Patients who received outpatient HSCT
  3. * Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures

Contacts and Locations

Study Contact

Hermioni Amonoo, MD, MPP, MPH
CONTACT
617-525-7472
hermioni_amonoo@dfci.harvard.edu
Isabella Larizza, BSc
CONTACT
ilarizza@bwh.harvard.edu

Principal Investigator

Hermioni Amonoo, MD, MPP, MPH
PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital

Study Locations (Sites)

Moffitt Cancer Center
Tampa, Florida, 33612
United States
Dana Farber Cancer Institute
Boston, Massachusetts, 02215
United States
Duke Cancer Institute
Durham, North Carolina, 27710
United States

Collaborators and Investigators

Sponsor: Brigham and Women's Hospital

  • Hermioni Amonoo, MD, MPP, MPH, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-20
Study Completion Date2030-04-30

Study Record Updates

Study Start Date2024-11-20
Study Completion Date2030-04-30

Terms related to this study

Keywords Provided by Researchers

  • stem cell transplant
  • positive psychology intervention

Additional Relevant MeSH Terms

  • Hematopoietic Stem Cell Transplant